2017   2016   2015   2014   2013   2012   2011   2010   2009   2008  

11. July 2017

ELISA for detection of TG6 autoantibodies



Zedira kits

Zedira logo Transglutaminase-Newsletter | July 2017


ZediXclusive TG6-ab ELISA kits E103 and E104:
Revised versions of ELISA kits E003 and E004.

Improvements:
•    Background subtraction not necessary anymore.
Therefore, now you can measure up to 40 sera in duplicates with one kit (96 wells).
The calibrators are adapted, so that the more relevant lower titers are covered.
Titers (U/mL) obtained by the new E103/E104 kits can be translated to titers of old kit versions E003/E004 and vice versa!
Cutoffs are redefined based on a sera collective of 86 patients with various neurological disorders, and 38 blood donors, equally distributed by sex and age.

Read more!

Get your serum sample measured for TG6 autoantibodies!

In co-operation with the medical laboratory of Prof. Dr. med. M. Kramer (board-certified clinical pathologist) in Heidelberg, Germany we provide testing services for the determination of Transglutaminase auto-antibodies in patient serum samples.

Link to Order Sheet (English) Link to Order Sheet (German)
  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland